Windward Bio Group AG (WWB) Stock Price & Analysis
Windward Bio Group AG (WWB) is trading at USD 23.32, down 9.48% today, as of November 18, 2026 at 20:43 UTC (US market open; quotes may be delayed), according to Nexqual market data.
WWB last closed at USD 23.32; today's session has ranged USD 21.03–29.92 on volume of 330,149 shares. Market capitalization is —, with a 52-week range of USD 18.35–33.99 (NMS). Source: Nexqual, retrieved November 18, 2026 at 20:43 UTC.
Also available as compact Markdown for AI agents: nexqual.com/WWB.md
Key facts (WWB)
- Total return with dividends: 1Y -18.2% vs S&P 500 +11.9%; 5Y -18.2% vs S&P 500 +66.7%.
- Dividend: WWB paid no cash dividend in the last five years.
Total return (dividends reinvested) (WWB)
| 1Y (from 2026-11-13) | 5Y (from 2026-11-09) | |
|---|---|---|
| Total return | -18.2% | -18.2% |
| S&P 500 (SPY) | +11.9% | +66.7% |
| Per year | — | — |
| Volatility (annualized) | 169.8% | 0.8% |
| Max drawdown | -22.4% (Nov 2026→Nov 2026) | -18.2% (Nov 2026→Nov 2026) |
Dividends (WWB)
WWB paid no cash dividend in the last five years.
WWB recent SEC filings (last 120 days)
| Filed | Form | What it says |
|---|---|---|
| Nov 16, 2026 | 6-K | Current report (foreign issuer) · period ended Nov 16, 2026 |
Source: SEC EDGAR. Quotes are the opening words of each item as filed; each form links to the filing. Insider Form 4 filings are listed in the insider sections.
WWB analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |
Key Statistics (as of November 18, 2026 at 20:43 UTC)
| Price | USD 23.32 |
|---|---|
| Change | ▼ 9.48% (down) |
| Previous Close | USD 23.32 |
| Open | USD 23.32 |
| Day Range | USD 21.03 – 29.92 |
| 52-Week Range | USD 18.35 – 33.99 |
| Volume | 330,149 shares |
| Market Cap | — |
| Exchange | NMS |
Earnings (WWB)
Source: Nexqual, November 18, 2026 at 20:43 UTC.
Financials & Fundamentals (WWB)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Debt / Equity | 0 |
| Current Ratio | 8.57 |
| Total Cash | $186.47M |
| Total Debt | $474,000 |
Source: Nexqual, November 18, 2026 at 20:43 UTC.
Financial Health Score (WWB)
Nexqual rates Windward Bio Group AG's overall financial health "Mixed" across five dimensions, as of November 18, 2026 at 20:43 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% (last 12 months) |
| Balance Sheet | Strong — $186M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$49M (TTM) |
| Efficiency | Mixed — No data |
Ownership (WWB)
| Insider Ownership | +14.08% |
|---|---|
| Institutional Ownership | +42.38% |
| Shares Outstanding | 58.04M |
| Float | 38.04M |
Source: Nexqual, November 18, 2026 at 20:43 UTC.
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: November 18, 2026 at 20:43 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt